SCÉIL
LIVE

Serial Number

79143384

Owner

CELLECTIS

Filing Date

Aug 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SCÉIL Trademark

Serial Number: 79143384 • Registration: 5211208

SCÉIL is a trademark filed by CELLECTIS on August 19, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CELLECTIS (10 trademarks)

102 avenue Gaston Roussel

Entity Type: 99

Trademark Details

Filing Date

August 19, 2013

Registration Date

May 30, 2017

Published for Opposition

March 14, 2017

Cancellation Date

August 18, 2023

Goods & Services

Biological preparations for medical, therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; chemical and biochemical preparations for medical, therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; chemical pharmaceutical products, namely, chemical preparations for pharmaceutical purposes for treating cancer, pharmaceutical preparations for use in chemotherapy, engineered stem cells for use in regenerative medicine; cultures and preparations of micro-organisms for medical or therapeutic, pharmaceutical and veterinary use, namely, human and animal cells in the nature of biological tissue cultures; bacteriological preparations for medical, therapeutic, pharmaceutical and veterinary use

Collection and preservation of human blood; medical services relating to the collection, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical services, namely, sampling, collection and banking of human cells for therapeutic purposes; blood bank services; collection and storage of human cells and blood, rental of medical equipment

Scientific and industrial research, namely, research and development of new products, biological research, bacteriological research, chemistry research, technical research in the field of storage and therapeutic uses of human or animal cells, scientific research for medical, therapeutic and diagnostic purposes; scientific research in the field of storage and therapeutic uses of human or animal cells; scientific research for medical and veterinary purposes in the field of storage and therapeutic uses of human or animal cells; scientific analysis in the field of storage and potential autologous therapeutic purposes; research and development of biochemical analysis, biological analysis and molecular biology techniques, namely, research in the field of storage and therapeutic uses of human or animal cells; research and development of new molecules for use in industry, preparation of biological materials, particularly of stem cells, namely, biological engineering, genetic engineering; scientific laboratory services; technical project studies, namely, engineering, surveying, computer programming, design and development of software and multimedia products, all the aforesaid services exclusively intended for storage and/or therapeutic uses of human or animal cells; scientific and industrial research and development in the fields of genetic, medical and veterinary diagnostics and biotechnology; chemical, biochemical and biotechnological laboratory services; scientific advice in the field of biotechnology

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 17, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 17, 2024 DETH
CANCELLED SECTION 71
Dec 15, 2023 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 12, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 27, 2017 FINO
NOTIFICATION PROCESSED BY IB
Oct 6, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 7, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 30, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
May 30, 2017 R.PR
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2017 OP2R
NOTICE OF PUBLICATION
Feb 22, 2017 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 9, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2017 CNSA
ASSIGNED TO EXAMINER
Dec 27, 2016 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2016 TROA
NON-FINAL ACTION MAILED
Jun 7, 2016 CNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2016 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 4, 2016 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2015 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 28, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 12, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 12, 2015 OPNR
ASSIGNED TO EXAMINER
Jun 26, 2015 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 23, 2015 RCSC
LETTER OF SUSPENSION MAILED
Oct 16, 2014 CNSL
SUSPENSION LETTER WRITTEN
Oct 15, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 CRFA
ASSIGNED TO LIE
Sep 16, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2014 TROA
REFUSAL PROCESSED BY IB
Apr 4, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2014 RFCS
REFUSAL PROCESSED BY MPU
Mar 14, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 11, 2014 MAFR
ASSIGNED TO EXAMINER
Mar 7, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 6, 2014 REPR